查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942503

2026年全球口腔给药系统市场报告

Buccal Drug Delivery System Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，口服药物递送系统市场发展迅速，预计将从2025年的38.9亿美元成长到2026年的43.2亿美元，复合年增长率达11.2%。过去几年的成长可归因于多种因素，例如：人们对替代给药途径的偏好日益增强、慢性疼痛和心绞痛治疗药物使用量的增加、黏膜黏附製剂技术的进步、对速效药物需求的增长以及口服药物生产规模的扩大。

预计未来几年口腔给药系统市场将快速成长，到2030年市场规模将达到64.8亿美元，复合年增长率（CAGR）为10.7%。预测期内的成长要素包括：对粘膜给药研究投入的增加、戒烟疗法需求的增长、个性化给药系统的推广、对提高遵守用药的製剂的日益重视以及新型口服药物的研发。预测期内的主要趋势包括：口腔和舌下给药剂型的广泛应用、对快速药物吸收系统的需求不断增长、对患者友好型给药方式的日益重视、缓释口腔製剂的推广以及对非侵入性治疗的日益重视。

慢性病盛行率的不断上升预计将推动未来口服给药系统市场的成长。慢性病是指持续一年以上的健康状况，例如癌症、心臟病、中风、糖尿病和关节炎。这些疾病被归类为最常见的慢性病，​​虽然可以控制但难以治愈，需要持续的医疗护理和营养管理。口服给药系统为粘膜和粘膜给药提供了一种有效且合适的给药方式，这对于许多患有糖尿病和癌症等慢性病的患者来说至关重要。例如，2023年9月，总部位于瑞士的联合国专门机构世界卫生组织（世卫组织）报告称，每年有4,100万人死于非传染性疾病（NCDs）或慢性病，占全球死亡总数的74%。其中，1,790万人死于心血管疾病，930万人死于癌症，410万人死于慢性呼吸道疾病，200万人死于糖尿病。慢性病发病率的上升趋势正在推动口腔给药系统市场的成长。

为了支持营收成长，主要企业正致力于推出新产品，例如褪黑素口腔喷雾。褪黑素口腔喷雾剂是一种以喷雾形式口服的褪黑素补充剂，使用方便高效。例如，2023年2月，印度製药公司Allac Biotech Private Limited推出了褪黑素口腔喷雾。本产品透过简单有效的给药方式，支持人体自身褪黑素的分泌，进而改善睡眠品质。它能快速缓解入睡困难、睡眠维持困难或难以适应睡眠时间变化等问题。由于其在口腔内吸收迅速，该喷雾剂有助于患者更快入睡，并有助于整体改善睡眠品质。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球口腔给药系统市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术和循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 口腔和舌下给药形式的采用率不断提高
    • 对快速药物吸收系统的需求不断增长
    • 越来越关注以病人为中心的药物传递方式
    • 缓释口服製剂的扩展
    • 非侵入性治疗方法将变得越来越重要

第五章 终端用户产业市场分析

  • 医院
  • 门诊治疗中心
  • 专科诊所
  • 製药公司
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球口腔给药系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球口腔给药系统市场规模、比较及成长率分析
  • 全球口腔给药系统市场表现：规模与成长，2020-2025年
  • 全球口腔给药系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 舌下片、口腔含片及锭剂、口腔喷雾剂
  • 透过使用
  • 疼痛管理、戒烟辅助、心绞痛
  • 最终用户
  • 医院、门诊护理中心和其他最终用户
  • 按类型细分：舌下
  • 舌下片、舌下膜
  • 按类型细分：口腔含片和锭剂
  • 口腔含片，口腔锭剂
  • 按类型细分：口腔喷雾剂
  • 喷雾溶液，喷雾凝胶

第十章 区域与国家分析

  • 全球口腔给药系统市场：区域分析、预测与展望（2020-2025年、2025-2030年预测、2035年预测）
  • 全球口腔给药系统市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 口腔给药系统市场：竞争格局及市场份额，2024年
  • 口腔给药系统市场：公司估值矩阵
  • 口腔给药系统市场：公司概况
    • Teva Pharmaceuticals Industries Ltd
    • Pfizer Incorporated
    • GlaxoSmithKline Public Limited Company
    • Indivior PLC
    • Generex Biotechnology Corporation

第37章：其他领先和创新企业

  • Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年口腔给药系统市场：提供新机会的国家
  • 2030年口腔给药系统市场：充满新机会的细分市场
  • 2030年口腔给药系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MBDDS01_G26Q1

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

Tariffs are impacting the buccal drug delivery system market by increasing costs of imported pharmaceutical excipients, packaging materials, specialized manufacturing equipment, and quality testing instruments. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported formulation inputs, while Asia-Pacific faces cost pressure on finished product exports. These tariffs are increasing production costs and extending development timelines. However, they are also supporting local excipient production, regional manufacturing expansion, and innovation in cost-efficient formulation technologies.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.89 billion in 2025 to $4.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing preference for alternative drug delivery routes, growth in chronic pain and angina treatments, advancements in mucoadhesive formulations, rising demand for faster onset medications, expansion of oral pharmaceutical manufacturing.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing investments in transmucosal drug research, rising demand for smoking cessation therapies, expansion of personalized drug delivery systems, growing focus on compliance-friendly formulations, increasing development of novel buccal drugs. Major trends in the forecast period include increasing adoption of buccal and sublingual dosage forms, rising demand for rapid drug absorption systems, growing focus on patient-friendly drug delivery, expansion of controlled-release buccal formulations, enhanced emphasis on non-invasive therapies.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

Leading players in the buccal drug delivery systems space are emphasizing new product introductions, such as melatonin oral sprays, to support revenue growth. A melatonin oral spray is a melatonin supplement delivered in a spray form for oral administration, enabling convenient and efficient use. For example, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical company, introduced a melatonin oral spray. The product supports the body's natural melatonin production, helping to enhance sleep quality through a simple and effective delivery method. It provides rapid relief for individuals experiencing difficulty falling asleep, staying asleep, or adapting to changing sleep schedules. Owing to its fast and easy oral absorption, the spray enables a quicker onset of sleep and contributes to improved overall sleep quality.

In April 2023, DifGen Pharmaceuticals LLC, a United States-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. for an undisclosed consideration. The transaction was intended to enhance patient access to essential, life-saving medicines that are consistently high in quality and offered at affordable costs. This acquisition enabled DifGen to strengthen its research and development and manufacturing capabilities, while supporting a secure supply chain and the production of complex dosage forms for its partners through localized manufacturing operations in the United States. Aveva Drug Delivery Services Inc. is a United States-based company specializing in buccal drug delivery system solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc

North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
  • 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
  • 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
  • Subsegments:
  • 1) By Sublingual: Sublingual Tablets; Sublingual Films
  • 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
  • 3) By Oral Sprays: Spray Solutions; Spray Gels
  • Companies Mentioned: Teva Pharmaceuticals Industries Ltd; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation; Catalent Inc; Arx Limited Liability Company; BioDelivery Science International Incorporated; Cynapsus Therapeutics Incorporated; Endo Pharmaceuticals Public Limited Company; Medlab Clinical Ltd; AstraZeneca PLC; Dr. Reddy's Laboratories Ltd; Takeda Pharmaceutical Company Limited; Novartis AG; Sanofi SA; Bayer AG; Adare Pharmaceuticals Inc; NAPP Pharmaceutical Ltd; Perrigo Company PLC; Reckitt Benckiser Group PLC; Teligent Pharma Inc; Par Pharmaceutical Companies Inc; Acorda Therapeutics Inc; Opiant Pharmaceuticals Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Buccal Drug Delivery System Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Buccal Drug Delivery System Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Buccal Drug Delivery System Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Buccal Drug Delivery System Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Buccal And Sublingual Dosage Forms
    • 4.2.2 Rising Demand For Rapid Drug Absorption Systems
    • 4.2.3 Growing Focus On Patient-Friendly Drug Delivery
    • 4.2.4 Expansion Of Controlled-Release Buccal Formulations
    • 4.2.5 Enhanced Emphasis On Non-Invasive Therapies

5. Buccal Drug Delivery System Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Centers
  • 5.3 Specialty Clinics
  • 5.4 Pharmaceutical Companies
  • 5.5 Research Laboratories

6. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Buccal Drug Delivery System Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Buccal Drug Delivery System Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Buccal Drug Delivery System Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Buccal Drug Delivery System Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Buccal Drug Delivery System Market Segmentation

  • 9.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sublingual, Buccal Tablets And Lozenges, Oral Sprays
  • 9.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Smoking Cessation, Angina Pectoris
  • 9.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Centers, Other End-Users
  • 9.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sublingual Tablets, Sublingual Films
  • 9.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Buccal Tablets, Buccal Lozenges
  • 9.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spray Solutions, Spray Gels

10. Buccal Drug Delivery System Market Regional And Country Analysis

  • 10.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Buccal Drug Delivery System Market

  • 11.1. Asia-Pacific Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Buccal Drug Delivery System Market

  • 12.1. China Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Buccal Drug Delivery System Market

  • 13.1. India Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Buccal Drug Delivery System Market

  • 14.1. Japan Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Buccal Drug Delivery System Market

  • 15.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Buccal Drug Delivery System Market

  • 16.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Buccal Drug Delivery System Market

  • 17.1. South Korea Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Buccal Drug Delivery System Market

  • 18.1. Taiwan Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Buccal Drug Delivery System Market

  • 19.1. South East Asia Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Buccal Drug Delivery System Market

  • 20.1. Western Europe Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Buccal Drug Delivery System Market

  • 21.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Buccal Drug Delivery System Market

  • 22.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Buccal Drug Delivery System Market

  • 23.1. France Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Buccal Drug Delivery System Market

  • 24.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Buccal Drug Delivery System Market

  • 25.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Buccal Drug Delivery System Market

  • 26.1. Eastern Europe Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Buccal Drug Delivery System Market

  • 27.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Buccal Drug Delivery System Market

  • 28.1. North America Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Buccal Drug Delivery System Market

  • 29.1. USA Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Buccal Drug Delivery System Market

  • 30.1. Canada Buccal Drug Delivery System Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Buccal Drug Delivery System Market

  • 31.1. South America Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Buccal Drug Delivery System Market

  • 32.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Buccal Drug Delivery System Market

  • 33.1. Middle East Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Buccal Drug Delivery System Market

  • 34.1. Africa Buccal Drug Delivery System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Buccal Drug Delivery System Market Regulatory and Investment Landscape

36. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

  • 36.1. Buccal Drug Delivery System Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Buccal Drug Delivery System Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Buccal Drug Delivery System Market Company Profiles
    • 36.3.1. Teva Pharmaceuticals Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Buccal Drug Delivery System Market Other Major And Innovative Companies

  • Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC

38. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

40. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

  • 40.1 Buccal Drug Delivery System Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Buccal Drug Delivery System Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Buccal Drug Delivery System Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer